

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | definitive hemopoiesis (GO:0060216) | 7.73148951 |
| 2 | ribosomal small subunit assembly (GO:0000028) | 7.58173894 |
| 3 | platelet dense granule organization (GO:0060155) | 6.24075246 |
| 4 | endothelium development (GO:0003158) | 6.21481980 |
| 5 | positive regulation of vasculogenesis (GO:2001214) | 5.74549624 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.50677183 |
| 7 | viral transcription (GO:0019083) | 5.31951170 |
| 8 | megakaryocyte development (GO:0035855) | 5.31342014 |
| 9 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.20167830 |
| 10 | translational termination (GO:0006415) | 5.12227693 |
| 11 | aggressive behavior (GO:0002118) | 5.04863858 |
| 12 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.89686194 |
| 13 | polyketide metabolic process (GO:0030638) | 4.68925665 |
| 14 | doxorubicin metabolic process (GO:0044598) | 4.68925665 |
| 15 | daunorubicin metabolic process (GO:0044597) | 4.68925665 |
| 16 | DNA deamination (GO:0045006) | 4.66145103 |
| 17 | endosome to melanosome transport (GO:0035646) | 4.62587784 |
| 18 | endosome to pigment granule transport (GO:0043485) | 4.62587784 |
| 19 | translational elongation (GO:0006414) | 4.56969534 |
| 20 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.47347892 |
| 21 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.47347892 |
| 22 | ribosomal small subunit biogenesis (GO:0042274) | 4.46881752 |
| 23 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.39438706 |
| 24 | cotranslational protein targeting to membrane (GO:0006613) | 4.28539793 |
| 25 | response to interferon-beta (GO:0035456) | 4.26794055 |
| 26 | regulation of penile erection (GO:0060405) | 4.25543325 |
| 27 | protein targeting to ER (GO:0045047) | 4.25172590 |
| 28 | response to interferon-alpha (GO:0035455) | 4.22403933 |
| 29 | maturation of SSU-rRNA (GO:0030490) | 4.21847591 |
| 30 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 4.21551314 |
| 31 | lymphoid progenitor cell differentiation (GO:0002320) | 4.17604827 |
| 32 | secretory granule organization (GO:0033363) | 4.15425792 |
| 33 | valine metabolic process (GO:0006573) | 4.14359916 |
| 34 | regulation of skeletal muscle contraction (GO:0014819) | 4.13752010 |
| 35 | extracellular fibril organization (GO:0043206) | 4.10359192 |
| 36 | protein localization to endoplasmic reticulum (GO:0070972) | 4.06789678 |
| 37 | mature B cell differentiation involved in immune response (GO:0002313) | 4.06717880 |
| 38 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.05995596 |
| 39 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.03952673 |
| 40 | regulation of female receptivity (GO:0045924) | 3.92930009 |
| 41 | viral life cycle (GO:0019058) | 3.91837468 |
| 42 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.89368134 |
| 43 | regulation of vasculogenesis (GO:2001212) | 3.86002845 |
| 44 | angiogenesis involved in wound healing (GO:0060055) | 3.84589001 |
| 45 | positive regulation of B cell differentiation (GO:0045579) | 3.82775553 |
| 46 | L-fucose catabolic process (GO:0042355) | 3.79885158 |
| 47 | fucose catabolic process (GO:0019317) | 3.79885158 |
| 48 | L-fucose metabolic process (GO:0042354) | 3.79885158 |
| 49 | blood vessel maturation (GO:0001955) | 3.78381273 |
| 50 | protein neddylation (GO:0045116) | 3.75975552 |
| 51 | cellular protein complex disassembly (GO:0043624) | 3.71566103 |
| 52 | seminiferous tubule development (GO:0072520) | 3.69063088 |
| 53 | necroptotic process (GO:0070266) | 3.67565381 |
| 54 | epithelial cell differentiation involved in kidney development (GO:0035850) | 3.65154376 |
| 55 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.64582738 |
| 56 | response to vitamin E (GO:0033197) | 3.62872394 |
| 57 | translational initiation (GO:0006413) | 3.60717439 |
| 58 | regulation of platelet aggregation (GO:0090330) | 3.54548703 |
| 59 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.52583153 |
| 60 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.52066538 |
| 61 | autophagic vacuole fusion (GO:0000046) | 3.50692672 |
| 62 | embryonic hemopoiesis (GO:0035162) | 3.46740578 |
| 63 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.44765460 |
| 64 | regulation of platelet activation (GO:0010543) | 3.43089339 |
| 65 | cell differentiation involved in metanephros development (GO:0072202) | 3.41233797 |
| 66 | regulation of integrin activation (GO:0033623) | 3.40941497 |
| 67 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.39372748 |
| 68 | protein complex disassembly (GO:0043241) | 3.38730561 |
| 69 | female mating behavior (GO:0060180) | 3.37330198 |
| 70 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.37061278 |
| 71 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.36129314 |
| 72 | lymph node development (GO:0048535) | 3.35224294 |
| 73 | T cell homeostasis (GO:0043029) | 3.34102860 |
| 74 | platelet aggregation (GO:0070527) | 3.33801489 |
| 75 | DNA strand elongation (GO:0022616) | 3.31206476 |
| 76 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.30798378 |
| 77 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.30079003 |
| 78 | fibril organization (GO:0097435) | 3.29333008 |
| 79 | positive regulation of transforming growth factor beta production (GO:0071636) | 3.29098421 |
| 80 | IMP metabolic process (GO:0046040) | 3.24707214 |
| 81 | myeloid cell development (GO:0061515) | 3.23830636 |
| 82 | telomere maintenance via recombination (GO:0000722) | 3.23156129 |
| 83 | parental behavior (GO:0060746) | 3.22405639 |
| 84 | regulation of erythrocyte differentiation (GO:0045646) | 3.20050874 |
| 85 | hematopoietic stem cell proliferation (GO:0071425) | 3.19936223 |
| 86 | organelle membrane fusion (GO:0090174) | 3.19774300 |
| 87 | mRNA catabolic process (GO:0006402) | 3.19124686 |
| 88 | purine-containing compound salvage (GO:0043101) | 3.18810570 |
| 89 | sleep (GO:0030431) | 3.16608200 |
| 90 | macromolecular complex disassembly (GO:0032984) | 3.16134276 |
| 91 | cGMP biosynthetic process (GO:0006182) | 3.15020107 |
| 92 | IMP biosynthetic process (GO:0006188) | 3.14623529 |
| 93 | maternal behavior (GO:0042711) | 3.12293338 |
| 94 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.08184749 |
| 95 | Peyers patch development (GO:0048541) | 3.06921827 |
| 96 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.06921827 |
| 97 | pseudouridine synthesis (GO:0001522) | 3.02503982 |
| 98 | RNA catabolic process (GO:0006401) | 3.01464869 |
| 99 | growth hormone receptor signaling pathway (GO:0060396) | 2.99478618 |
| 100 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.99114029 |
| 101 | DNA unwinding involved in DNA replication (GO:0006268) | 2.98476147 |
| 102 | ribosomal large subunit biogenesis (GO:0042273) | 2.97584979 |
| 103 | relaxation of smooth muscle (GO:0044557) | 2.96824316 |
| 104 | mature B cell differentiation (GO:0002335) | 2.95442087 |
| 105 | DNA replication initiation (GO:0006270) | 2.95290896 |
| 106 | adenosine metabolic process (GO:0046085) | 2.90773502 |
| 107 | respiratory chain complex IV assembly (GO:0008535) | 2.90049452 |
| 108 | mast cell activation (GO:0045576) | 2.89633877 |
| 109 | programmed necrotic cell death (GO:0097300) | 2.89330384 |
| 110 | positive regulation of granulocyte differentiation (GO:0030854) | 2.88734705 |
| 111 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.88594027 |
| 112 | fatty acid transmembrane transport (GO:1902001) | 2.88247932 |
| 113 | phospholipid scrambling (GO:0017121) | 2.87738015 |
| 114 | muscle filament sliding (GO:0030049) | 2.87661021 |
| 115 | actin-myosin filament sliding (GO:0033275) | 2.87661021 |
| 116 | toxin transport (GO:1901998) | 2.87501549 |
| 117 | mitotic recombination (GO:0006312) | 2.84632865 |
| 118 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.84280331 |
| 119 | cardiolipin metabolic process (GO:0032048) | 2.83075646 |
| 120 | dopamine transport (GO:0015872) | 2.82513373 |
| 121 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.81703379 |
| 122 | purine nucleotide salvage (GO:0032261) | 2.81012994 |
| 123 | regulation of natural killer cell differentiation (GO:0032823) | 2.80476074 |
| 124 | phagocytosis, recognition (GO:0006910) | 2.80071421 |
| 125 | thrombin receptor signaling pathway (GO:0070493) | 2.79191980 |
| 126 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.77861630 |
| 127 | regulation of necroptotic process (GO:0060544) | 2.77524437 |
| 128 | actin-mediated cell contraction (GO:0070252) | 2.76307800 |
| 129 | response to protozoan (GO:0001562) | 2.75479039 |
| 130 | cytokine production involved in immune response (GO:0002367) | 2.75434797 |
| 131 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.75317053 |
| 132 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.75317053 |
| 133 | defense response to protozoan (GO:0042832) | 2.73980863 |
| 134 | regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803) | 2.73488680 |
| 135 | protein targeting to membrane (GO:0006612) | 2.73421756 |
| 136 | cellular response to growth hormone stimulus (GO:0071378) | 2.73110431 |
| 137 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.72888843 |
| 138 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.72888843 |
| 139 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.72764151 |
| 140 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.69762446 |
| 141 | mast cell degranulation (GO:0043303) | 2.68256838 |
| 142 | mast cell activation involved in immune response (GO:0002279) | 2.68256838 |
| 143 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.67512422 |
| 144 | negative regulation of viral genome replication (GO:0045071) | 2.66901647 |
| 145 | blood coagulation, intrinsic pathway (GO:0007597) | 2.66283030 |
| 146 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.65876858 |
| 147 | telomere maintenance via telomere lengthening (GO:0010833) | 2.64823382 |
| 148 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.63918328 |
| 149 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.63277539 |
| 150 | negative regulation of norepinephrine secretion (GO:0010700) | 2.62077846 |
| 151 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.62064347 |
| 152 | negative regulation of phagocytosis (GO:0050765) | 2.61984627 |
| 153 | regulation of necrotic cell death (GO:0010939) | 2.61930724 |
| 154 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.61826411 |
| 155 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.61411335 |
| 156 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.61237720 |
| 157 | UV protection (GO:0009650) | 2.61135094 |
| 158 | nitric oxide mediated signal transduction (GO:0007263) | 2.60877669 |
| 159 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.60049414 |
| 160 | branched-chain amino acid metabolic process (GO:0009081) | 2.59774945 |
| 161 | protein heterotrimerization (GO:0070208) | 2.59560347 |
| 162 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.59355102 |
| 163 | execution phase of apoptosis (GO:0097194) | 2.59333326 |
| 164 | B cell activation involved in immune response (GO:0002312) | 2.59267470 |
| 165 | metallo-sulfur cluster assembly (GO:0031163) | 2.59213713 |
| 166 | negative regulation of muscle contraction (GO:0045932) | 2.58779075 |
| 167 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.57170453 |
| 168 | rRNA modification (GO:0000154) | 2.57026251 |
| 169 | negative regulation of protein localization to cell surface (GO:2000009) | 2.56172432 |
| 170 | interkinetic nuclear migration (GO:0022027) | 2.55819889 |
| 171 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.54732623 |
| 172 | relaxation of muscle (GO:0090075) | 2.53319696 |
| 173 | ubiquinone biosynthetic process (GO:0006744) | 2.52140511 |
| 174 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.50143331 |
| 175 | granulocyte differentiation (GO:0030851) | 2.49886819 |
| 176 | negative regulation of appetite (GO:0032099) | 2.49775551 |
| 177 | negative regulation of response to food (GO:0032096) | 2.49775551 |
| 178 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.46733378 |
| 179 | positive regulation of odontogenesis (GO:0042482) | 2.46332798 |
| 180 | monoamine transport (GO:0015844) | 2.46159364 |
| 181 | leukocyte tethering or rolling (GO:0050901) | 2.43954054 |
| 182 | positive regulation of glomerulus development (GO:0090193) | 2.43905492 |
| 183 | hematopoietic stem cell differentiation (GO:0060218) | 2.43522785 |
| 184 | glomerular filtration (GO:0003094) | 2.42391865 |
| 185 | cell wall macromolecule catabolic process (GO:0016998) | 2.40664216 |
| 186 | positive regulation of catecholamine secretion (GO:0033605) | 2.37775263 |
| 187 | piRNA metabolic process (GO:0034587) | 2.36838557 |
| 188 | ketone biosynthetic process (GO:0042181) | 2.36142546 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCL_19346495_ChIP-Seq_HPC-7_Human | 5.35823339 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.21094937 |
| 3 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.58731052 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.35031145 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.31625775 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.25141396 |
| 7 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.23715743 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.18969972 |
| 9 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 3.15846574 |
| 10 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.14044412 |
| 11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.00238613 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.82421950 |
| 13 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.77416209 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.70570765 |
| 15 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.69525871 |
| 16 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.61298202 |
| 17 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.59029288 |
| 18 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.55836338 |
| 19 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.42738292 |
| 20 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.42592973 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.41940521 |
| 22 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.38414826 |
| 23 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.38145663 |
| 24 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.33722702 |
| 25 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.32041571 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.20114667 |
| 27 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.19383889 |
| 28 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.19371191 |
| 29 | VDR_22108803_ChIP-Seq_LS180_Human | 2.17020490 |
| 30 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.15670187 |
| 31 | MYC_22102868_ChIP-Seq_BL_Human | 2.14416936 |
| 32 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 2.11580684 |
| 33 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 2.11580684 |
| 34 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.09696843 |
| 35 | GATA1_19941826_ChIP-Seq_K562_Human | 2.05024058 |
| 36 | * FUS_26573619_Chip-Seq_HEK293_Human | 2.03848847 |
| 37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.01615767 |
| 38 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.00280198 |
| 39 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.99937615 |
| 40 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.99612863 |
| 41 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.99167737 |
| 42 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.97857598 |
| 43 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.96221720 |
| 44 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.94728113 |
| 45 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.94268395 |
| 46 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.90916546 |
| 47 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.90806056 |
| 48 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.89717247 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89702541 |
| 50 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.89374292 |
| 51 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.89290346 |
| 52 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.88479535 |
| 53 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.86603786 |
| 54 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.84203277 |
| 55 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.81463636 |
| 56 | EWS_26573619_Chip-Seq_HEK293_Human | 1.80432419 |
| 57 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.78818327 |
| 58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.74868938 |
| 59 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.74402939 |
| 60 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.72904176 |
| 61 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.72510084 |
| 62 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.69894194 |
| 63 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.69553289 |
| 64 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.64452590 |
| 65 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.64067990 |
| 66 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.63539829 |
| 67 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63270793 |
| 68 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.62739431 |
| 69 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.61622106 |
| 70 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.60735741 |
| 71 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.60303119 |
| 72 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.60237635 |
| 73 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.59913848 |
| 74 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.54103051 |
| 75 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.52746594 |
| 76 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.52477759 |
| 77 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.52231463 |
| 78 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.51864534 |
| 79 | MYB_26560356_Chip-Seq_TH2_Human | 1.51390199 |
| 80 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.49379654 |
| 81 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.48987228 |
| 82 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.47949407 |
| 83 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.46796393 |
| 84 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.43849543 |
| 85 | MYB_26560356_Chip-Seq_TH1_Human | 1.42304402 |
| 86 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.41972641 |
| 87 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.40858634 |
| 88 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.40686658 |
| 89 | CJUN_26792858_Chip-Seq_BT549_Human | 1.39205842 |
| 90 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.39038946 |
| 91 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.38542713 |
| 92 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.36884020 |
| 93 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.36524911 |
| 94 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.36426482 |
| 95 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.34389046 |
| 96 | MAF_26560356_Chip-Seq_TH1_Human | 1.33074526 |
| 97 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.32932522 |
| 98 | AR_20517297_ChIP-Seq_VCAP_Human | 1.32873518 |
| 99 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.31006261 |
| 100 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.29729539 |
| 101 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.28868479 |
| 102 | UTX_26944678_Chip-Seq_JUKART_Human | 1.28545740 |
| 103 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.27916489 |
| 104 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.27220502 |
| 105 | * ERG_20517297_ChIP-Seq_VCAP_Human | 1.27026640 |
| 106 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.25686162 |
| 107 | * EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.23064221 |
| 108 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.22411997 |
| 109 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.21035659 |
| 110 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20827531 |
| 111 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.20267971 |
| 112 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.20106049 |
| 113 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.17631019 |
| 114 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.17308916 |
| 115 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.17132116 |
| 116 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.15733662 |
| 117 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.14819947 |
| 118 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.13478662 |
| 119 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.13478662 |
| 120 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.13308645 |
| 121 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.12494455 |
| 122 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.12442403 |
| 123 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.11890417 |
| 124 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.10150058 |
| 125 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.10082654 |
| 126 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.10028268 |
| 127 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.09631080 |
| 128 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.09265913 |
| 129 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09264527 |
| 130 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09169970 |
| 131 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.08713165 |
| 132 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.07931318 |
| 133 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.07669378 |
| 134 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.06860345 |
| 135 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06752232 |
| 136 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.06661905 |
| 137 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.06334229 |
| 138 | GATA3_26560356_Chip-Seq_TH2_Human | 1.05629864 |
| 139 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03666412 |
| 140 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.02790916 |
| 141 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.01901577 |
| 142 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.01562343 |
| 143 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.00182383 |
| 144 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.99276352 |
| 145 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.98888911 |
| 146 | * SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.95157866 |
| 147 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.95146375 |
| 148 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94570048 |
| 149 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.94227871 |
| 150 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.94216183 |
| 151 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.93539870 |
| 152 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.91723220 |
| 153 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.90661018 |
| 154 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.90308312 |
| 155 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.90308312 |
| 156 | SPI1_23127762_ChIP-Seq_K562_Human | 0.90101917 |
| 157 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.89751842 |
| 158 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.89448595 |
| 159 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89127953 |
| 160 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.88891109 |
| 161 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.88592736 |
| 162 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88585769 |
| 163 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.87494421 |
| 164 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.87062623 |
| 165 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.86623846 |
| 166 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.86600304 |
| 167 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.86195719 |
| 168 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.85296294 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002396_abnormal_hematopoietic_system | 4.91348134 |
| 2 | MP0004808_abnormal_hematopoietic_stem | 4.19382075 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 4.08542793 |
| 4 | MP0004147_increased_porphyrin_level | 3.27786856 |
| 5 | MP0000465_gastrointestinal_hemorrhage | 3.17855992 |
| 6 | MP0005397_hematopoietic_system_phenotyp | 3.14691804 |
| 7 | MP0001545_abnormal_hematopoietic_system | 3.14691804 |
| 8 | MP0005503_abnormal_tendon_morphology | 3.12493782 |
| 9 | MP0005174_abnormal_tail_pigmentation | 3.06599209 |
| 10 | MP0005464_abnormal_platelet_physiology | 3.01313005 |
| 11 | MP0006054_spinal_hemorrhage | 2.74069166 |
| 12 | MP0005670_abnormal_white_adipose | 2.71205049 |
| 13 | MP0005075_abnormal_melanosome_morpholog | 2.68163808 |
| 14 | MP0005275_abnormal_skin_tensile | 2.66943418 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.64122346 |
| 16 | MP0000013_abnormal_adipose_tissue | 2.37678281 |
| 17 | MP0000685_abnormal_immune_system | 2.27372298 |
| 18 | MP0002095_abnormal_skin_pigmentation | 2.27188099 |
| 19 | MP0009785_altered_susceptibility_to | 2.22781926 |
| 20 | MP0004036_abnormal_muscle_relaxation | 2.19372636 |
| 21 | MP0003724_increased_susceptibility_to | 2.18241468 |
| 22 | MP0009278_abnormal_bone_marrow | 2.17189216 |
| 23 | MP0000490_abnormal_crypts_of | 2.13314434 |
| 24 | MP0004145_abnormal_muscle_electrophysio | 2.10269946 |
| 25 | MP0003763_abnormal_thymus_physiology | 2.08727881 |
| 26 | MP0002398_abnormal_bone_marrow | 2.07548011 |
| 27 | MP0005671_abnormal_response_to | 2.06116773 |
| 28 | MP0009379_abnormal_foot_pigmentation | 2.05882457 |
| 29 | MP0003943_abnormal_hepatobiliary_system | 1.93547448 |
| 30 | MP0009697_abnormal_copulation | 1.92759292 |
| 31 | MP0008007_abnormal_cellular_replicative | 1.91348542 |
| 32 | MP0000230_abnormal_systemic_arterial | 1.90483305 |
| 33 | MP0008004_abnormal_stomach_pH | 1.88902834 |
| 34 | MP0005646_abnormal_pituitary_gland | 1.88109998 |
| 35 | MP0002166_altered_tumor_susceptibility | 1.85770620 |
| 36 | MP0000689_abnormal_spleen_morphology | 1.77539198 |
| 37 | MP0001986_abnormal_taste_sensitivity | 1.76808839 |
| 38 | MP0005025_abnormal_response_to | 1.69456203 |
| 39 | MP0002722_abnormal_immune_system | 1.67837870 |
| 40 | MP0008058_abnormal_DNA_repair | 1.65281077 |
| 41 | MP0004272_abnormal_basement_membrane | 1.65262354 |
| 42 | MP0010094_abnormal_chromosome_stability | 1.62478857 |
| 43 | MP0008775_abnormal_heart_ventricle | 1.60470018 |
| 44 | MP0010368_abnormal_lymphatic_system | 1.60157137 |
| 45 | MP0000751_myopathy | 1.59540301 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.59530895 |
| 47 | MP0003303_peritoneal_inflammation | 1.58262259 |
| 48 | MP0000716_abnormal_immune_system | 1.57336652 |
| 49 | MP0002420_abnormal_adaptive_immunity | 1.56798748 |
| 50 | MP0002429_abnormal_blood_cell | 1.56229143 |
| 51 | MP0001873_stomach_inflammation | 1.54603351 |
| 52 | MP0001819_abnormal_immune_cell | 1.54044297 |
| 53 | MP0001800_abnormal_humoral_immune | 1.53984062 |
| 54 | MP0002452_abnormal_antigen_presenting | 1.52368132 |
| 55 | MP0001853_heart_inflammation | 1.51887897 |
| 56 | MP0003693_abnormal_embryo_hatching | 1.50512106 |
| 57 | MP0003950_abnormal_plasma_membrane | 1.49561474 |
| 58 | MP0002723_abnormal_immune_serum | 1.48607870 |
| 59 | MP0001188_hyperpigmentation | 1.47800254 |
| 60 | MP0002877_abnormal_melanocyte_morpholog | 1.43195153 |
| 61 | MP0006292_abnormal_olfactory_placode | 1.42675861 |
| 62 | MP0001542_abnormal_bone_strength | 1.42466507 |
| 63 | MP0003828_pulmonary_edema | 1.41481354 |
| 64 | MP0002148_abnormal_hypersensitivity_rea | 1.41247880 |
| 65 | MP0002006_tumorigenesis | 1.40875684 |
| 66 | MP0003806_abnormal_nucleotide_metabolis | 1.39701760 |
| 67 | MP0005595_abnormal_vascular_smooth | 1.39628680 |
| 68 | MP0001661_extended_life_span | 1.39267446 |
| 69 | MP0003866_abnormal_defecation | 1.39200796 |
| 70 | MP0002108_abnormal_muscle_morphology | 1.37012389 |
| 71 | MP0000015_abnormal_ear_pigmentation | 1.29751545 |
| 72 | MP0005165_increased_susceptibility_to | 1.28693842 |
| 73 | MP0000703_abnormal_thymus_morphology | 1.28241447 |
| 74 | MP0003567_abnormal_fetal_cardiomyocyte | 1.27826965 |
| 75 | MP0004215_abnormal_myocardial_fiber | 1.27703680 |
| 76 | MP0005000_abnormal_immune_tolerance | 1.27495660 |
| 77 | MP0003646_muscle_fatigue | 1.26613536 |
| 78 | MP0008057_abnormal_DNA_replication | 1.26428525 |
| 79 | MP0003279_aneurysm | 1.26331186 |
| 80 | MP0001879_abnormal_lymphatic_vessel | 1.26095965 |
| 81 | MP0006276_abnormal_autonomic_nervous | 1.24951082 |
| 82 | MP0003718_maternal_effect | 1.24915366 |
| 83 | MP0006036_abnormal_mitochondrial_physio | 1.24573709 |
| 84 | MP0009384_cardiac_valve_regurgitation | 1.22053937 |
| 85 | MP0003077_abnormal_cell_cycle | 1.21477149 |
| 86 | MP0002419_abnormal_innate_immunity | 1.19839716 |
| 87 | MP0002138_abnormal_hepatobiliary_system | 1.19767043 |
| 88 | MP0003436_decreased_susceptibility_to | 1.14265359 |
| 89 | MP0005620_abnormal_muscle_contractility | 1.13362475 |
| 90 | MP0002938_white_spotting | 1.09908448 |
| 91 | MP0005385_cardiovascular_system_phenoty | 1.09084848 |
| 92 | MP0001544_abnormal_cardiovascular_syste | 1.09084848 |
| 93 | MP0006138_congestive_heart_failure | 1.08811577 |
| 94 | MP0003252_abnormal_bile_duct | 1.07423442 |
| 95 | MP0004084_abnormal_cardiac_muscle | 1.07333321 |
| 96 | MP0002019_abnormal_tumor_incidence | 1.04258320 |
| 97 | MP0004484_altered_response_of | 1.04211232 |
| 98 | MP0000681_abnormal_thyroid_gland | 1.02880692 |
| 99 | MP0000343_altered_response_to | 1.02838410 |
| 100 | MP0002971_abnormal_brown_adipose | 1.01524039 |
| 101 | MP0005508_abnormal_skeleton_morphology | 1.01522595 |
| 102 | MP0000749_muscle_degeneration | 1.01422110 |
| 103 | MP0002295_abnormal_pulmonary_circulatio | 1.00104906 |
| 104 | MP0002132_abnormal_respiratory_system | 0.95144564 |
| 105 | MP0003959_abnormal_lean_body | 0.94348518 |
| 106 | MP0009333_abnormal_splenocyte_physiolog | 0.94296593 |
| 107 | MP0001790_abnormal_immune_system | 0.94029872 |
| 108 | MP0005387_immune_system_phenotype | 0.94029872 |
| 109 | MP0000313_abnormal_cell_death | 0.93416168 |
| 110 | MP0005410_abnormal_fertilization | 0.92159607 |
| 111 | MP0005390_skeleton_phenotype | 0.92152925 |
| 112 | MP0003868_abnormal_feces_composition | 0.90461780 |
| 113 | MP0004957_abnormal_blastocyst_morpholog | 0.90382596 |
| 114 | MP0010386_abnormal_urinary_bladder | 0.90217656 |
| 115 | MP0002405_respiratory_system_inflammati | 0.90168908 |
| 116 | MP0005369_muscle_phenotype | 0.89189941 |
| 117 | MP0000759_abnormal_skeletal_muscle | 0.87715145 |
| 118 | MP0005666_abnormal_adipose_tissue | 0.87674169 |
| 119 | MP0001664_abnormal_digestion | 0.87390578 |
| 120 | MP0001851_eye_inflammation | 0.87265026 |
| 121 | MP0001845_abnormal_inflammatory_respons | 0.87215516 |
| 122 | MP0000372_irregular_coat_pigmentation | 0.86946159 |
| 123 | MP0002075_abnormal_coat/hair_pigmentati | 0.86507187 |
| 124 | MP0003172_abnormal_lysosome_physiology | 0.82680159 |
| 125 | MP0005409_darkened_coat_color | 0.82514319 |
| 126 | MP0005535_abnormal_body_temperature | 0.82194228 |
| 127 | MP0001533_abnormal_skeleton_physiology | 0.81207358 |
| 128 | MP0008469_abnormal_protein_level | 0.80315201 |
| 129 | MP0002106_abnormal_muscle_physiology | 0.79597725 |
| 130 | MP0000249_abnormal_blood_vessel | 0.79407615 |
| 131 | MP0004087_abnormal_muscle_fiber | 0.76827507 |
| 132 | MP0002972_abnormal_cardiac_muscle | 0.76825137 |
| 133 | MP0010352_gastrointestinal_tract_polyps | 0.76525835 |
| 134 | MP0005375_adipose_tissue_phenotype | 0.74800469 |
| 135 | MP0009250_abnormal_appendicular_skeleto | 0.73764044 |
| 136 | MP0010329_abnormal_lipoprotein_level | 0.72824100 |
| 137 | MP0004130_abnormal_muscle_cell | 0.72588133 |
| 138 | MP0000477_abnormal_intestine_morphology | 0.72166614 |
| 139 | MP0005084_abnormal_gallbladder_morpholo | 0.71337343 |
| 140 | MP0003045_fibrosis | 0.70395980 |
| 141 | MP0005330_cardiomyopathy | 0.69439948 |
| 142 | MP0001764_abnormal_homeostasis | 0.68908890 |
| 143 | MP0002127_abnormal_cardiovascular_syste | 0.68767999 |
| 144 | MP0005023_abnormal_wound_healing | 0.68646071 |
| 145 | MP0005171_absent_coat_pigmentation | 0.68095661 |
| 146 | MP0002128_abnormal_blood_circulation | 0.67026120 |
| 147 | MP0002009_preneoplasia | 0.66579197 |
| 148 | MP0002733_abnormal_thermal_nociception | 0.66495317 |
| 149 | MP0000598_abnormal_liver_morphology | 0.65407444 |
| 150 | MP0003186_abnormal_redox_activity | 0.65354366 |
| 151 | MP0002160_abnormal_reproductive_system | 0.64705779 |
| 152 | MP0009764_decreased_sensitivity_to | 0.64703093 |
| 153 | MP0004134_abnormal_chest_morphology | 0.64097295 |
| 154 | MP0002837_dystrophic_cardiac_calcinosis | 0.63748853 |
| 155 | MP0003656_abnormal_erythrocyte_physiolo | 0.63325355 |
| 156 | MP0001175_abnormal_lung_morphology | 0.62907330 |
| 157 | MP0003111_abnormal_nucleus_morphology | 0.62875549 |
| 158 | MP0005164_abnormal_response_to | 0.61388488 |
| 159 | MP0002928_abnormal_bile_duct | 0.60780945 |
| 160 | MP0003638_abnormal_response/metabolism_ | 0.60406215 |
| 161 | MP0001348_abnormal_lacrimal_gland | 0.60211550 |
| 162 | MP0001293_anophthalmia | 0.58051563 |
| 163 | MP0002933_joint_inflammation | 0.57339946 |
| 164 | MP0003786_premature_aging | 0.56193032 |
| 165 | MP0001958_emphysema | 0.55351141 |
| 166 | MP0009765_abnormal_xenobiotic_induced | 0.55002697 |
| 167 | MP0003221_abnormal_cardiomyocyte_apopto | 0.54702662 |
| 168 | MP0002089_abnormal_postnatal_growth/wei | 0.54416070 |
| 169 | MP0009763_increased_sensitivity_to | 0.54061455 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Thrombocytosis (HP:0001894) | 5.84012708 |
| 2 | Prolonged bleeding time (HP:0003010) | 5.60942537 |
| 3 | Aplastic anemia (HP:0001915) | 5.55672330 |
| 4 | Nemaline bodies (HP:0003798) | 4.82835599 |
| 5 | Petechiae (HP:0000967) | 4.78281553 |
| 6 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.61094584 |
| 7 | Type 1 muscle fiber predominance (HP:0003803) | 4.61014284 |
| 8 | Muscle fiber inclusion bodies (HP:0100299) | 4.53698495 |
| 9 | Abnormal number of erythroid precursors (HP:0012131) | 4.49828223 |
| 10 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.48706433 |
| 11 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.15872851 |
| 12 | IgM deficiency (HP:0002850) | 4.02147625 |
| 13 | Aortic aneurysm (HP:0004942) | 3.94203930 |
| 14 | Chronic otitis media (HP:0000389) | 3.93830082 |
| 15 | Epistaxis (HP:0000421) | 3.77100606 |
| 16 | Type 2 muscle fiber atrophy (HP:0003554) | 3.69530645 |
| 17 | Reduced antithrombin III activity (HP:0001976) | 3.68075967 |
| 18 | Reticulocytopenia (HP:0001896) | 3.65450591 |
| 19 | Purpura (HP:0000979) | 3.61355939 |
| 20 | Muscle fiber atrophy (HP:0100295) | 3.60371331 |
| 21 | Myositis (HP:0100614) | 3.59268024 |
| 22 | Impaired platelet aggregation (HP:0003540) | 3.55357413 |
| 23 | Abnormal platelet function (HP:0011869) | 3.55357413 |
| 24 | Type I transferrin isoform profile (HP:0003642) | 3.45995894 |
| 25 | Acute myeloid leukemia (HP:0004808) | 3.44314298 |
| 26 | Protrusio acetabuli (HP:0003179) | 3.34961809 |
| 27 | Aortic dissection (HP:0002647) | 3.34216977 |
| 28 | Amaurosis fugax (HP:0100576) | 3.31410488 |
| 29 | Abnormal platelet volume (HP:0011876) | 3.16070896 |
| 30 | Premature rupture of membranes (HP:0001788) | 3.07771396 |
| 31 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.06415385 |
| 32 | Rhabdomyolysis (HP:0003201) | 3.02708688 |
| 33 | Gingival bleeding (HP:0000225) | 2.99618665 |
| 34 | Pallor (HP:0000980) | 2.97807589 |
| 35 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.96311940 |
| 36 | Facial diplegia (HP:0001349) | 2.89801988 |
| 37 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.85933623 |
| 38 | Increased mean platelet volume (HP:0011877) | 2.79193063 |
| 39 | Abnormal delivery (HP:0001787) | 2.77755024 |
| 40 | Myelodysplasia (HP:0002863) | 2.77279145 |
| 41 | Acute lymphatic leukemia (HP:0006721) | 2.74325669 |
| 42 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.73700270 |
| 43 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.73700270 |
| 44 | Abnormal protein glycosylation (HP:0012346) | 2.73700270 |
| 45 | Abnormal glycosylation (HP:0012345) | 2.73700270 |
| 46 | Menorrhagia (HP:0000132) | 2.73359301 |
| 47 | Spinal rigidity (HP:0003306) | 2.72944274 |
| 48 | Redundant skin (HP:0001582) | 2.72197809 |
| 49 | Abnormality of T cell physiology (HP:0011840) | 2.68843587 |
| 50 | Distal arthrogryposis (HP:0005684) | 2.68472244 |
| 51 | Mesomelia (HP:0003027) | 2.67151270 |
| 52 | Myoglobinuria (HP:0002913) | 2.65377517 |
| 53 | Round ear (HP:0100830) | 2.65371900 |
| 54 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.60642405 |
| 55 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.60642405 |
| 56 | Hypothermia (HP:0002045) | 2.60246456 |
| 57 | Follicular hyperkeratosis (HP:0007502) | 2.57395848 |
| 58 | Colon cancer (HP:0003003) | 2.55522725 |
| 59 | Panhypogammaglobulinemia (HP:0003139) | 2.55142467 |
| 60 | Spinal cord lesions (HP:0100561) | 2.54435448 |
| 61 | Syringomyelia (HP:0003396) | 2.54435448 |
| 62 | Fatigue (HP:0012378) | 2.52790758 |
| 63 | Increased variability in muscle fiber diameter (HP:0003557) | 2.52255026 |
| 64 | Peritonitis (HP:0002586) | 2.52210356 |
| 65 | Albinism (HP:0001022) | 2.52093525 |
| 66 | Pancytopenia (HP:0001876) | 2.51768084 |
| 67 | Breech presentation (HP:0001623) | 2.51037760 |
| 68 | Abnormality of the nasal mucosa (HP:0000433) | 2.51004424 |
| 69 | Dyschromatopsia (HP:0007641) | 2.49659242 |
| 70 | Nonprogressive disorder (HP:0003680) | 2.49361307 |
| 71 | Exercise-induced myalgia (HP:0003738) | 2.47791103 |
| 72 | Ulnar deviation of the wrist (HP:0003049) | 2.47482213 |
| 73 | Absent phalangeal crease (HP:0006109) | 2.47111384 |
| 74 | Neck muscle weakness (HP:0000467) | 2.46369692 |
| 75 | Abnormality of the prostate (HP:0008775) | 2.44580651 |
| 76 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.37414531 |
| 77 | Recurrent bronchitis (HP:0002837) | 2.36093854 |
| 78 | Arterial thrombosis (HP:0004420) | 2.35227373 |
| 79 | Bruising susceptibility (HP:0000978) | 2.30726866 |
| 80 | Weak cry (HP:0001612) | 2.30451123 |
| 81 | Cellulitis (HP:0100658) | 2.27856345 |
| 82 | Recurrent viral infections (HP:0004429) | 2.27435491 |
| 83 | Patchy hypopigmentation of hair (HP:0011365) | 2.25135189 |
| 84 | Central scotoma (HP:0000603) | 2.24631983 |
| 85 | Bile duct proliferation (HP:0001408) | 2.23064105 |
| 86 | Abnormal biliary tract physiology (HP:0012439) | 2.23064105 |
| 87 | Myotonia (HP:0002486) | 2.23056682 |
| 88 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.22619882 |
| 89 | 11 pairs of ribs (HP:0000878) | 2.20504676 |
| 90 | Orchitis (HP:0100796) | 2.19347865 |
| 91 | Spontaneous hematomas (HP:0007420) | 2.17137406 |
| 92 | Microcytic anemia (HP:0001935) | 2.16747118 |
| 93 | Soft skin (HP:0000977) | 2.13900875 |
| 94 | Type II lissencephaly (HP:0007260) | 2.13058761 |
| 95 | Gonadotropin excess (HP:0000837) | 2.13038475 |
| 96 | Abnormality of the columella (HP:0009929) | 2.12836494 |
| 97 | Hyperthyroidism (HP:0000836) | 2.11479123 |
| 98 | Rimmed vacuoles (HP:0003805) | 2.10710071 |
| 99 | Renal cortical cysts (HP:0000803) | 2.09847276 |
| 100 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.08367649 |
| 101 | Macrocytic anemia (HP:0001972) | 2.08094393 |
| 102 | Decreased skull ossification (HP:0004331) | 2.06802668 |
| 103 | Increased intramyocellular lipid droplets (HP:0012240) | 2.05514736 |
| 104 | Beaking of vertebral bodies (HP:0004568) | 2.04875073 |
| 105 | Cerebral palsy (HP:0100021) | 2.04682844 |
| 106 | Poikiloderma (HP:0001029) | 2.04119672 |
| 107 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.03229153 |
| 108 | Short 1st metacarpal (HP:0010034) | 2.03229153 |
| 109 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.01797418 |
| 110 | Slender build (HP:0001533) | 2.01432779 |
| 111 | Ragged-red muscle fibers (HP:0003200) | 2.00773161 |
| 112 | Abnormal pupillary function (HP:0007686) | 2.00548571 |
| 113 | Metaphyseal dysplasia (HP:0100255) | 1.99727109 |
| 114 | Agammaglobulinemia (HP:0004432) | 1.99089521 |
| 115 | Increased muscle lipid content (HP:0009058) | 1.98434045 |
| 116 | Areflexia of lower limbs (HP:0002522) | 1.96605163 |
| 117 | Abnormality of the renal cortex (HP:0011035) | 1.95768204 |
| 118 | Hepatocellular necrosis (HP:0001404) | 1.94780520 |
| 119 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.94686816 |
| 120 | Abnormal finger flexion creases (HP:0006143) | 1.94025593 |
| 121 | Muscle stiffness (HP:0003552) | 1.93637951 |
| 122 | Chest pain (HP:0100749) | 1.93529330 |
| 123 | Bladder diverticulum (HP:0000015) | 1.92519728 |
| 124 | Tinnitus (HP:0000360) | 1.90488157 |
| 125 | Lymphoma (HP:0002665) | 1.90144732 |
| 126 | Hepatic necrosis (HP:0002605) | 1.89675694 |
| 127 | B lymphocytopenia (HP:0010976) | 1.86613322 |
| 128 | Abnormality of B cell number (HP:0010975) | 1.86613322 |
| 129 | Exertional dyspnea (HP:0002875) | 1.86223333 |
| 130 | Gastrointestinal stroma tumor (HP:0100723) | 1.85755785 |
| 131 | Erythema (HP:0010783) | 1.85492570 |
| 132 | Venous insufficiency (HP:0005293) | 1.84939963 |
| 133 | Hypoproteinemia (HP:0003075) | 1.84866305 |
| 134 | Abnormality of T cells (HP:0002843) | 1.84849385 |
| 135 | Nasal polyposis (HP:0100582) | 1.84214435 |
| 136 | Deformed tarsal bones (HP:0008119) | 1.84113588 |
| 137 | Encephalitis (HP:0002383) | 1.82603810 |
| 138 | Polycythemia (HP:0001901) | 1.81700094 |
| 139 | Migraine (HP:0002076) | 1.81375995 |
| 140 | Abnormality of skull ossification (HP:0002703) | 1.81031037 |
| 141 | Spontaneous abortion (HP:0005268) | 1.80723637 |
| 142 | Asplenia (HP:0001746) | 1.79622555 |
| 143 | Optic neuritis (HP:0100653) | 1.79130649 |
| 144 | Retrobulbar optic neuritis (HP:0100654) | 1.79130649 |
| 145 | Generalized aminoaciduria (HP:0002909) | 1.78561213 |
| 146 | Oligomenorrhea (HP:0000876) | 1.78359497 |
| 147 | IgG deficiency (HP:0004315) | 1.78159248 |
| 148 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.76992810 |
| 149 | Calf muscle hypertrophy (HP:0008981) | 1.76561653 |
| 150 | Medulloblastoma (HP:0002885) | 1.76244127 |
| 151 | Radial bowing (HP:0002986) | 1.76168229 |
| 152 | Esophageal neoplasm (HP:0100751) | 1.76106044 |
| 153 | Neoplasm of head and neck (HP:0012288) | 1.76106044 |
| 154 | Abnormality of macular pigmentation (HP:0008002) | 1.75687313 |
| 155 | Hypoplasia of the thymus (HP:0000778) | 1.75637225 |
| 156 | Abnormality of the costochondral junction (HP:0000919) | 1.75167046 |
| 157 | Broad face (HP:0000283) | 1.75100196 |
| 158 | Brushfield spots (HP:0001088) | 1.74781303 |
| 159 | Muscle fiber splitting (HP:0003555) | 1.73988438 |
| 160 | Autoimmune hemolytic anemia (HP:0001890) | 1.73507599 |
| 161 | Neutropenia (HP:0001875) | 1.73311188 |
| 162 | Fragile skin (HP:0001030) | 1.71303133 |
| 163 | Abnormality of the 1st metacarpal (HP:0010009) | 1.70155772 |
| 164 | Dilatation of the ascending aorta (HP:0005111) | 1.69323407 |
| 165 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.67616281 |
| 166 | Infantile muscular hypotonia (HP:0008947) | 1.67092001 |
| 167 | Pancreatic cysts (HP:0001737) | 1.65773101 |
| 168 | Venous abnormality (HP:0002624) | 1.65025416 |
| 169 | Abolished electroretinogram (ERG) (HP:0000550) | 1.63246604 |
| 170 | Ankle contracture (HP:0006466) | 1.63204895 |
| 171 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.62996962 |
| 172 | Potter facies (HP:0002009) | 1.58401193 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KIT | 3.46792656 |
| 2 | TNIK | 3.23806931 |
| 3 | TGFBR1 | 3.22430377 |
| 4 | TIE1 | 3.17117464 |
| 5 | MUSK | 2.87065661 |
| 6 | NME2 | 2.69180679 |
| 7 | EEF2K | 2.67677068 |
| 8 | MAP4K2 | 2.64446061 |
| 9 | MKNK1 | 2.52966381 |
| 10 | BTK | 2.50497511 |
| 11 | FLT3 | 2.46661803 |
| 12 | TEC | 2.45306588 |
| 13 | MAP4K1 | 2.26797443 |
| 14 | STK16 | 2.20358960 |
| 15 | WEE1 | 2.16084212 |
| 16 | ACVR1B | 2.09725349 |
| 17 | MAPKAPK5 | 2.06663302 |
| 18 | MATK | 2.05217332 |
| 19 | NUAK1 | 2.02777603 |
| 20 | JAK3 | 1.99452764 |
| 21 | MAP2K3 | 1.94170162 |
| 22 | TGFBR2 | 1.93635608 |
| 23 | CSF1R | 1.80188457 |
| 24 | RPS6KB2 | 1.78089351 |
| 25 | CDK19 | 1.66597064 |
| 26 | CDK8 | 1.57420317 |
| 27 | MAP3K12 | 1.53765247 |
| 28 | BRSK2 | 1.53330684 |
| 29 | BCKDK | 1.50317802 |
| 30 | PAK2 | 1.41698621 |
| 31 | FRK | 1.39814038 |
| 32 | ERN1 | 1.39743010 |
| 33 | ZAP70 | 1.38924470 |
| 34 | PHKG1 | 1.37223289 |
| 35 | PHKG2 | 1.37223289 |
| 36 | MKNK2 | 1.35413794 |
| 37 | MYLK | 1.34214547 |
| 38 | PBK | 1.27180275 |
| 39 | PKN2 | 1.26602269 |
| 40 | MAPKAPK3 | 1.25867311 |
| 41 | PIM2 | 1.21199553 |
| 42 | VRK1 | 1.20501232 |
| 43 | DAPK2 | 1.19495807 |
| 44 | CCNB1 | 1.18876196 |
| 45 | TXK | 1.18525503 |
| 46 | SYK | 1.18155128 |
| 47 | CDC7 | 1.15927001 |
| 48 | ADRBK1 | 1.15686607 |
| 49 | PLK4 | 1.10117088 |
| 50 | GRK5 | 1.07728926 |
| 51 | MAP2K6 | 1.05363641 |
| 52 | DYRK3 | 1.03682651 |
| 53 | MAP3K6 | 1.03005346 |
| 54 | PTK2B | 1.02307762 |
| 55 | CAMKK2 | 0.99851644 |
| 56 | NLK | 0.99367673 |
| 57 | TTN | 0.99011144 |
| 58 | PASK | 0.98816675 |
| 59 | GRK1 | 0.96070860 |
| 60 | PIK3CA | 0.94546221 |
| 61 | PIK3CG | 0.94183698 |
| 62 | IKBKE | 0.93193676 |
| 63 | PRKG2 | 0.93033403 |
| 64 | PLK2 | 0.91104424 |
| 65 | TNK2 | 0.89755668 |
| 66 | TBK1 | 0.87918693 |
| 67 | VRK2 | 0.87810557 |
| 68 | BMX | 0.86902461 |
| 69 | IKBKB | 0.85959423 |
| 70 | ATR | 0.84465302 |
| 71 | EIF2AK3 | 0.80916385 |
| 72 | CAMK1 | 0.78785208 |
| 73 | LYN | 0.77960196 |
| 74 | LRRK2 | 0.77622920 |
| 75 | SRPK1 | 0.77168844 |
| 76 | EIF2AK1 | 0.76600777 |
| 77 | CDK7 | 0.76289557 |
| 78 | ITK | 0.74362053 |
| 79 | MAP2K1 | 0.73016439 |
| 80 | IRAK4 | 0.71371939 |
| 81 | LCK | 0.71348534 |
| 82 | GRK7 | 0.69320112 |
| 83 | PIM1 | 0.69285071 |
| 84 | KDR | 0.68997302 |
| 85 | CLK1 | 0.67857650 |
| 86 | RIPK4 | 0.67477132 |
| 87 | TRPM7 | 0.66847454 |
| 88 | DDR2 | 0.65708162 |
| 89 | PDGFRA | 0.65592772 |
| 90 | MAPK4 | 0.64480162 |
| 91 | GRK6 | 0.63386307 |
| 92 | FES | 0.62766029 |
| 93 | MAPK12 | 0.62733170 |
| 94 | FER | 0.61828416 |
| 95 | ABL1 | 0.61673654 |
| 96 | ILK | 0.61403775 |
| 97 | DAPK3 | 0.61052371 |
| 98 | SCYL2 | 0.60750389 |
| 99 | PAK4 | 0.60248836 |
| 100 | IGF1R | 0.60235851 |
| 101 | CSNK1G3 | 0.59878892 |
| 102 | BMPR2 | 0.59223327 |
| 103 | MAP3K14 | 0.58957019 |
| 104 | ABL2 | 0.58290457 |
| 105 | MAPK7 | 0.56912664 |
| 106 | CDK3 | 0.56212307 |
| 107 | LATS1 | 0.54977947 |
| 108 | HIPK2 | 0.53082433 |
| 109 | MAP3K5 | 0.52693037 |
| 110 | CDK4 | 0.52678803 |
| 111 | DAPK1 | 0.51017135 |
| 112 | ERBB3 | 0.50504428 |
| 113 | SIK3 | 0.49564225 |
| 114 | TAOK3 | 0.49552529 |
| 115 | TSSK6 | 0.48668234 |
| 116 | EIF2AK2 | 0.48453509 |
| 117 | CSNK1G1 | 0.48381854 |
| 118 | PRKG1 | 0.47863307 |
| 119 | TYK2 | 0.47755952 |
| 120 | STK3 | 0.46796638 |
| 121 | PINK1 | 0.45289449 |
| 122 | BMPR1B | 0.45063169 |
| 123 | RPS6KA6 | 0.44720894 |
| 124 | ADRBK2 | 0.44281802 |
| 125 | ZAK | 0.42787254 |
| 126 | RPS6KB1 | 0.42558033 |
| 127 | RPS6KA4 | 0.42207915 |
| 128 | PRKCQ | 0.41403952 |
| 129 | MAPK11 | 0.40992969 |
| 130 | HCK | 0.39186513 |
| 131 | MAP3K7 | 0.38182628 |
| 132 | CSNK1G2 | 0.38011074 |
| 133 | AURKB | 0.37852273 |
| 134 | RAF1 | 0.36533310 |
| 135 | RPS6KA5 | 0.34453345 |
| 136 | MAPK3 | 0.33983043 |
| 137 | MAP3K13 | 0.33454173 |
| 138 | CHUK | 0.33411576 |
| 139 | NEK9 | 0.33279655 |
| 140 | BLK | 0.32581545 |
| 141 | OBSCN | 0.30901827 |
| 142 | NEK2 | 0.30323780 |
| 143 | FGFR3 | 0.27041287 |
| 144 | RPS6KL1 | 0.26892276 |
| 145 | RPS6KC1 | 0.26892276 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.83063982 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 4.73556873 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.61205034 |
| 4 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.96342204 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 2.83635984 |
| 6 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.36387105 |
| 7 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.28062141 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.22175690 |
| 9 | Homologous recombination_Homo sapiens_hsa03440 | 2.19659666 |
| 10 | Spliceosome_Homo sapiens_hsa03040 | 2.07374851 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.99822431 |
| 12 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.98775327 |
| 13 | RNA polymerase_Homo sapiens_hsa03020 | 1.98000208 |
| 14 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.95407956 |
| 15 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.94048333 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.91731415 |
| 17 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.84752896 |
| 18 | RNA degradation_Homo sapiens_hsa03018 | 1.84635198 |
| 19 | Platelet activation_Homo sapiens_hsa04611 | 1.83795903 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.77934685 |
| 21 | Olfactory transduction_Homo sapiens_hsa04740 | 1.71159913 |
| 22 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.68499325 |
| 23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.66123689 |
| 24 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.63770359 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.62807197 |
| 26 | Cell cycle_Homo sapiens_hsa04110 | 1.60619156 |
| 27 | Peroxisome_Homo sapiens_hsa04146 | 1.59631740 |
| 28 | Renin secretion_Homo sapiens_hsa04924 | 1.56936793 |
| 29 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.55411626 |
| 30 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.55110623 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.54667854 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.51758405 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.51282566 |
| 34 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.49431540 |
| 35 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.46475665 |
| 36 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.41709591 |
| 37 | Measles_Homo sapiens_hsa05162 | 1.35448175 |
| 38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.30732252 |
| 39 | Purine metabolism_Homo sapiens_hsa00230 | 1.30675039 |
| 40 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.29786236 |
| 41 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.27562035 |
| 42 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.26767185 |
| 43 | Leishmaniasis_Homo sapiens_hsa05140 | 1.25046539 |
| 44 | Thyroid cancer_Homo sapiens_hsa05216 | 1.24472861 |
| 45 | RNA transport_Homo sapiens_hsa03013 | 1.23129663 |
| 46 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.22497202 |
| 47 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.22361272 |
| 48 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.21014796 |
| 49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.16640825 |
| 50 | Basal transcription factors_Homo sapiens_hsa03022 | 1.11018102 |
| 51 | Salivary secretion_Homo sapiens_hsa04970 | 1.10681515 |
| 52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.10301555 |
| 53 | Proteasome_Homo sapiens_hsa03050 | 1.08853141 |
| 54 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.08702880 |
| 55 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.08387162 |
| 56 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.08152805 |
| 57 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.06369595 |
| 58 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.05435397 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.04820184 |
| 60 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.03767746 |
| 61 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.03120866 |
| 62 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.01939231 |
| 63 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.00789558 |
| 64 | Protein export_Homo sapiens_hsa03060 | 1.00438527 |
| 65 | Shigellosis_Homo sapiens_hsa05131 | 1.00349367 |
| 66 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.00237794 |
| 67 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.00035909 |
| 68 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.99835264 |
| 69 | Focal adhesion_Homo sapiens_hsa04510 | 0.99561629 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.98910603 |
| 71 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.97300384 |
| 72 | Long-term depression_Homo sapiens_hsa04730 | 0.95090780 |
| 73 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.94514186 |
| 74 | Phototransduction_Homo sapiens_hsa04744 | 0.94203926 |
| 75 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.93433638 |
| 76 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.91938992 |
| 77 | Legionellosis_Homo sapiens_hsa05134 | 0.90652151 |
| 78 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.89724951 |
| 79 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.88813846 |
| 80 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.88480126 |
| 81 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.88057257 |
| 82 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.87048003 |
| 83 | Galactose metabolism_Homo sapiens_hsa00052 | 0.85894229 |
| 84 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.84253985 |
| 85 | Hepatitis B_Homo sapiens_hsa05161 | 0.83950846 |
| 86 | Sulfur relay system_Homo sapiens_hsa04122 | 0.83792568 |
| 87 | Malaria_Homo sapiens_hsa05144 | 0.83522207 |
| 88 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.81048925 |
| 89 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.80356167 |
| 90 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.79344922 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.75193994 |
| 92 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.74959941 |
| 93 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.74147168 |
| 94 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.73909497 |
| 95 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.73767383 |
| 96 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.73477517 |
| 97 | Influenza A_Homo sapiens_hsa05164 | 0.70217266 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | 0.68738634 |
| 99 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.68630670 |
| 100 | Parkinsons disease_Homo sapiens_hsa05012 | 0.67993703 |
| 101 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.67372772 |
| 102 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.66889883 |
| 103 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65813472 |
| 104 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.65435783 |
| 105 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.63652708 |
| 106 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.63516717 |
| 107 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.63264709 |
| 108 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62846492 |
| 109 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.62683647 |
| 110 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.62675522 |
| 111 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62122159 |
| 112 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61961174 |
| 113 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.61953515 |
| 114 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.60473688 |
| 115 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.59947830 |
| 116 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.59771952 |
| 117 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.58888083 |
| 118 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.58743930 |
| 119 | Pertussis_Homo sapiens_hsa05133 | 0.58549839 |
| 120 | Melanoma_Homo sapiens_hsa05218 | 0.56291644 |
| 121 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.55788745 |
| 122 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.55722152 |
| 123 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.54807716 |
| 124 | Other glycan degradation_Homo sapiens_hsa00511 | 0.54760271 |
| 125 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.54301691 |
| 126 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.54171999 |
| 127 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.53805342 |
| 128 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.53801198 |
| 129 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.53734626 |
| 130 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.53497891 |
| 131 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.53203430 |
| 132 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.53075893 |
| 133 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.51456750 |
| 134 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.51055971 |
| 135 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50400268 |
| 136 | Gap junction_Homo sapiens_hsa04540 | 0.49978233 |
| 137 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.49330037 |
| 138 | Apoptosis_Homo sapiens_hsa04210 | 0.47964327 |
| 139 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47184194 |
| 140 | Carbon metabolism_Homo sapiens_hsa01200 | 0.46354492 |
| 141 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46351582 |
| 142 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.45289910 |
| 143 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.45233156 |
| 144 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44581957 |
| 145 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44512720 |
| 146 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.42129475 |
| 147 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.41969745 |
| 148 | Asthma_Homo sapiens_hsa05310 | 0.40572811 |
| 149 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.40247816 |
| 150 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38961902 |
| 151 | Circadian entrainment_Homo sapiens_hsa04713 | 0.37952886 |
| 152 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.36996128 |
| 153 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.33901095 |
| 154 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.32479167 |
| 155 | Allograft rejection_Homo sapiens_hsa05330 | 0.30886055 |
| 156 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.30657953 |
| 157 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.30089160 |
| 158 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.29554546 |
| 159 | Hepatitis C_Homo sapiens_hsa05160 | 0.29190695 |
| 160 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.27501079 |
| 161 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.27382032 |
| 162 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.26501697 |
| 163 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.25884792 |
| 164 | Pathways in cancer_Homo sapiens_hsa05200 | 0.24948272 |

